Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.85p 0.80p 0.90p 0.85p 0.85p 0.85p 2,932,166.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.2 -0.0 - 22.48

Sareum Share Discussion Threads

Showing 27401 to 27424 of 27425 messages
Chat Pages: 1097  1096  1095  1094  1093  1092  1091  1090  1089  1088  1087  1086  Older
DateSubjectAuthorDiscuss
23/1/2017
11:17
Target price 4.5p......just for starters.
hazelst
23/1/2017
10:32
Why would there be news next week?
bobby.ifa
22/1/2017
21:45
news next week?
skez13
20/1/2017
12:41
Coming back Bobby. Don't fret!
btfd
20/1/2017
10:28
Bloody hell, another drop!
bobby.ifa
20/1/2017
10:15
lol bobby. Luckily, they've got roughly 45 years until they can touch it. One way or the other, SAR will have done its thing by then!! ;)
btfd
20/1/2017
00:37
btfd: don't look good for their Uni fees mate!
bobby.ifa
19/1/2017
21:35
good luck to you btfd. i'm sure it'll come good. A
ackkers
18/1/2017
16:53
Bought another £300 worth for both my kids junior Sipps, the two consecutive 33429 trades. They've got a grands worth each now, and a few large caps in there. Hopefully by the time they've finished school SAR is flying for them (or bought out!)
btfd
16/1/2017
22:32
Thanks ackers and timbo003 for that and a useful synopsis of the Sierra Conference presentation last week
cerrito
16/1/2017
15:47
:) yeah cheap skate here
btfd
16/1/2017
14:35
latest broker note hTTps://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EGz%2FWD2gYRctTo3RpFQsQDr
skez13
16/1/2017
13:23
Inserting upper case TT doesn't make it work as an active link unless you cough up however much it is nowadays to become a blue ADVFN subscriber, but it does allow a reader to copy and paste directly without replacing the xx with tt, so still worth doing. hTTps://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EGz%2FWD2gYRctTo3RpFQsQDr
timbo003
16/1/2017
13:11
lol didn't work either :)
btfd
16/1/2017
13:10
4.5p sounds good to me.. and heading onwards to 8p in 2018 if we aren't bought out.. thanks akkers.. here's the link with cap TshTTps://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EGz%2FWD2gYRctTo3RpFQsQDr
btfd
16/1/2017
09:53
>>>ackers, thanks for the link to the hybridian report I think the trick with the links is to go back and edit the post where ADVFN have unhelpfully altered link with using upper case T hTTp://www.hardmanandco.com/docs/default-source/company-docs/sareum-ltd-documents/27.09.16-chk1-licensing-agreement-with-pronai.pdf
timbo003
16/1/2017
09:42
each time I copy the http at the start gets altered to hxx so just delete the xx and replace with tt. A
ackkers
16/1/2017
09:42
hxxps://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EGz%2FWD2gYRctTo3RpFQsQDr
ackkers
16/1/2017
09:19
Cerrito: hxxps://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EGz%2FWD2gYRctTo3RpFQsQDr regards Ackkers
ackkers
14/1/2017
20:42
Slight correction to my earlier post. Pfizer do have a tyk2 inhibitor in the clinic. But not for RA and in Lupus it has been dropped after phase1. So it would appear while they have an interest in the area (still in trials for ibs and psoriasis) there may be issues on the molecule stopping it progressing in RA and Lupus which are the biggest market. So still think they may buy us if our molecule is demonstrably better than tbeirs
mrsapeslaptop
14/1/2017
20:08
Listened to Sierra’s presentation at last Wednesday’s JP Morgan Bio Tech showcase-hxxp://investor.sierraoncology.com/events-and-webcasts?item=14. A 28 odd minute presentation which gave an overview of how chk1 fits in to the overall scene-a good deal of which went over my head. From minute 13 discussed 737 in detail; extolled the virtues of ICR and said Sierra would continue to work closely with them and the Royal Marsden and specifically namechecked Dr Ruth Plummer. Said that they programme to release preliminary data by the end of this year and have data of a medical conference standard later in 2018 and also in 2018 look to see how they can expand the potential of 737. I would be interested in the comments of those who have a better handle on the tech side than I have.
cerrito
14/1/2017
20:07
How did you folks get hold of the Hybridian note?
cerrito
13/1/2017
19:59
Hyrbidian note exceedingly bullish and factual. 2p should be the order of the day here, just on what has happened so far.
professor pettigrew
13/1/2017
19:25
Thank you MrsApesLaptop, very good post
mrblonde77
Chat Pages: 1097  1096  1095  1094  1093  1092  1091  1090  1089  1088  1087  1086  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170124 05:13:02